Loading candles…
Shree Ganesh Remedies Ltd was incorporated in 1995. It operates in the pharmaceuticals and specialty chemicals industries, focusing on the manufacture of pharmaceutical drug intermediates for active pharmaceutical ingredients (APIs) and fine chemicals. The company specializes in complex chemistry and offers contract development and manufacturing organization (CDMO) services along with supplying niche chemical products. Its tailored chemical solutions serve applications in human health, veterinary health, and industrial sectors. Shree Ganesh Remedies Ltd caters to a global market spanning over 20 countries, including regions such as India, the European Union, and the United States. No information is provided regarding founders, key management, subsidiaries, notable projects, or stock exchange listings.
This page is a live market overview for SHREE GANESH REMEDIES LTD (SGRL) on the NSE. As a listed security, SHREE GANESH REMEDIES LTD is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for SGRL before placing trades on tick2trade.
As of the latest feed, SGRL last traded at ₹504.05 on NSE, down ₹14.3 (2.76%) from the previous close of ₹518.35. Today's session range is ₹504 – ₹525.5, against a 52-week band of ₹477.05 – ₹559.5. Traded volume today stands at 2.73K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for SGRL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether SGRL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for SHREE GANESH REMEDIES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in SGRL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated SGRL option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.